NCT00647660View on ClinicalTrials.gov

Fasting Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Healthy
Interventions
DRUG

Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg

80/5mg, single dose fasting

DRUG

Corzide® Tablets 80 mg/5 mg

80/5mg, single dose fasting

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00647660 - Fasting Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg | Biotech Hunter | Biotech Hunter